Notably, in both analyses, hypermethylation at ACSL4 (cg15536552) was shown to increase susceptibility to NASH, suggesting it as a potential biomarker for NAFLD progression. The gene discussed is ACSL4; the disease is metabolic dysfunction-associated steatotic liver disease.